WINT
Windtree Therapeutics Inc
Halal Rating :
Last Price
$0.22
Last updated:
Market Cap
-
7D Change
-13.01%
1 Year Change
-56.52%
Company Overview
Industries
Exchange
Next Earnings Date
Windtree Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for acute cardiovascular and pulmonary diseases. The company's lead product candidate is istaroxime, being developed for acute heart failure and early cardiogenic shock. The company is primarily in research and development phase, with no commercial products generating revenue yet.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Windtree Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.